Trials / Terminated
TerminatedNCT00171119
A Study in Patients With Diabetes Mellitus Type II of the Effect on Albuminuria of 24 Week Treatment With Valsartan, Benazepril, and Valsartan+Benazepril
A 24-Week Study to Assess Blood Pressure Independent Effects of Valsartan Treatment, Benazepril Treatment and Combination of Both Valsartan and Benazepril Treatment on Urinary Albumin Excretion Rate With Type II Diabetes Mellitus and Microalbuminuria
- Status
- Terminated
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 81 (actual)
- Sponsor
- Novartis Pharmaceuticals · Industry
- Sex
- All
- Age
- 35 Years – 75 Years
- Healthy volunteers
- —
Summary
The purpose of this study is to evaluate the efficacy of valsartan, benazepril or the combination of both in reduction of microalbuminuria in Type 2 diabetic patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | valsartan |
Timeline
- Start date
- 2004-01-01
- Primary completion
- 2005-03-01
- First posted
- 2005-09-15
- Last updated
- 2008-12-17
Locations
1 site across 1 country: Switzerland
Source: ClinicalTrials.gov record NCT00171119. Inclusion in this directory is not an endorsement.